2025 Drug Development healthcare technology 
Lloyd Price
DECEMBER 2, 2024
In 2025, HealthTech valuations are expected to continue their upward trajectory, driven by several key factors: 1. Technological Advancements: AI and Machine Learning: AI-powered diagnostics, drug discovery, and personalised medicine are revolutionising healthcare.
Lloyd Price
NOVEMBER 16, 2024
Exec Summary: Merative, formerly known as IBM Watson Health, is gearing up to introduce a range of new products in 2025. With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
NOVEMBER 8, 2024
Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.
Lloyd Price
FEBRUARY 9, 2025
Why is it "one to watch" in 2025? Regulatory hurdles: Ensuring that these technologies meet regulatory standards and are safe for use in healthcare. Looking Ahead: 2025 is likely to be a pivotal year for cognitive architecture in HealthTech. provides the fuel for training and refining these AI systems.
Lloyd Price
DECEMBER 2, 2024
The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. The wound care market is poised for significant growth in 2025 and beyond. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Lloyd Price
FEBRUARY 7, 2025
Companies with a strong technology moat are typically valued at a premium to those that do not have a moat. When evaluating a healthtech company, it's essential to consider the strength and sustainability of its technology moat.
Lloyd Price
OCTOBER 28, 2024
Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Expert insights. Personalized for you.
67 
Let's personalize your content